Here’s a concise update on Shigella infections based on the latest publicly available reporting.
-
Most recent summaries show rising attention to extensively drug-resistant Shigella (XDR Shigella) in the United States, with public health agencies highlighting that a subset of infections are resistant to multiple commonly used antibiotics and may require alternative management and strict infection control measures. This trend has been echoed by major outlets reporting on CDC briefings and national surveillance updates in 2023 and 2026, underscoring the need for susceptibility testing and diligent reporting to prevent spread. [sources vary, with CDC updates and major news outlets covering the topic]
-
Health authorities emphasize that while Shigella typically causes gastroenteritis with diarrhea, fever, and abdominal cramps, the resistant strains complicate treatment, and there is concern about transmission through person-to-person contact, food, water, and surfaces. Providers are advised to follow local surveillance data, perform stool testing with antibiotic susceptibility when indicated, and report cases to public health authorities. [sources vary, with CDC and public health summaries]
-
Public health messaging continues to stress prevention: hand hygiene, safe food handling, thorough cleaning of surfaces, and isolation of symptomatic individuals to limit spread, particularly in settings with vulnerable populations or close contact.
Illustrative note:
- The discussion around XDR Shigella is part of broader antimicrobial resistance monitoring. A front-line antibiotic that once worked may be ineffective for some strains, so clinicians rely on lab susceptibility results to guide therapy and infection-control decisions. This has been a recurring theme in recent reporting from health agencies and major outlets. [sources vary]
If you’d like, I can pull the latest, country-specific briefings (e.g., UK, US, Canada) and summarize them with direct citations, or provide a brief one-page briefing for healthcare settings in London.
Sources
2018 Title: Update – CDC Recommendations for Managing and Reporting Shigella Infections with Possible Reduced Susceptibility to Ciprofloxacin Summary: This Health Alert Network (HAN) Update provides current recommendations on management and reporting of Shigella infections that have been treated with ciprofloxacin or azithromycin and resulted in possible clinical treatment failure. This is a follow-up to HAN 401: CDC Recommendations for Diagnosing and Managing Shigella Strains with Possible...
www.cdc.govA CDC alert warns that drug-resistant Shigella infections have increased substantially in the U.S., with cases spreading domestically since 2011.
www.foxnews.comDoctors have limited options to treat the "extensively drug-resistant" strains of Shigella bacteria.
www.cbsnews.comIt’s called shigellosis, and comes from easily-spread bacteria that are proving to be more and more resistant to antibiotics.
www.fox9.comDoctors have limited options to treat the "extensively drug-resistant" strains of Shigella bacteria.
www.cbsnews.comShigella bacteria can spread easily from one person to another – and it only takes a small amount of the bacteria to make someone sick.
www.khou.comNews outlets cover a new warning from the CDC concerning a rise of serious gastrointestinal infections from the Shigella bacteria, which seems to be increasingly resistant to common antibiotics. Bird flu and Naegleria fowleri are also in the news.
kffhealthnews.orgThere are 450,000 infections each year including 240,000 cases that do not respond to regular treatment
www.independent.co.ukThe U.S. Centers for Disease Control and Prevention is warning about a rising number of 'extensively drug-resistant' shigella bacteria infections, also known as shigellosis.
www.ctvnews.caShigella symptoms include diarrhea, fever and stomach pain, and the CDC is calling it 'a public health threat"
people.com